Friday, May 4, 2018 | ||
6:30 - 7:00 am |
Registration |
|
7:10 - 8:25 am |
CME Breakfast Symposium |
Chair: Matthew R. Weir, MD |
Session I: Obesity and Lifestyle Medicine | ||
8:35 - 8:40 am |
Chair Introduction and Opening Remarks |
Chair: Robert H. Eckel, MD |
8:40 - 9:00 am |
Bariatric Surgery - State of the Art |
|
9:00 - 9:20 am |
What You Need to Know: Complications of Bariatric Surgery |
|
9:20 - 9:40 am |
Cardiovascular/Metabolic Benefits of Bariatric Surgery |
|
9:40 - 10:00 am |
Panel Discussion and Q&A |
Chair: Robert H. Eckel, MD |
10:05 - 10:35 am |
Morning Break & Exhibits |
|
10:40 - 11:10 am |
Keynote Presentation |
|
11:10 - 11:30 am |
Benefits of Physical Activity and Exercise on Cardiovascular and Mental Health |
|
11:30 - 11:50 am |
Navigating Weight Loss Management in Diabetic Patients with CV Risk |
|
11:50 am - 12:10 pm |
Panel Discussion and Q&A |
Chair: Robert H. Eckel, MD |
12:10 pm |
Closing Remarks |
|
12:20 - 1:35 pm |
PME Lunch Symposium (NON-CME) |
|
Session II: Dyslipidemia/Atherosclerosis | ||
1:45 - 1:50 pm |
Chair Introduction |
Chair: Christie M. Ballantyne, MD |
1:50 - 2:10 pm |
Advances in Lipid Therapy: Non-statin Drugs and New Approaches |
|
2:10 - 2:30 pm |
It’s Time for Consensus: Defining Familial Hypercholesterolemia |
|
2:30 - 2:50 pm |
Importance of Lifestyle Modifications in Lipid Management |
|
2:55 - 3:25 pm |
Afternoon Break & Exhibits |
|
3:30 - 3:50 pm |
Updates in Severe Hypertriglyceridemia Treatment |
|
3:50 - 4:10 pm |
Navigating the Diagnosis and Treatment of Hypertriglyceridemia in Patients with High CV Risk |
|
4:10 - 4:30 pm |
Integrating Evidence-Based Data and Guidelines into Clinical Practice |
|
4:30 - 5:10 pm |
Challenging Patient Cases: The Triglyceride Dilemma |
Presenters: Robert H. Eckel, MD Panel: Yehuda Handelsman, MD; |
5:10 - 5:30 pm |
Panel Discussion and Q&A |
Chair: Christie M. Ballantyne, MD |
5:30 pm |
Closing Remarks |
Chair: Christie M. Ballantyne, MD |
5:35 - 6:35 pm |
Networking Reception |
|
6:45 - 8:00 pm |
PME Dinner Symposium (NON-CME) |
Saturday, May 5, 2018 | ||||||||
7:00 - 7:30 am |
Registration |
|||||||
7:40 - 8:55 am |
CME Breakfast Symposium |
Chair: Clyde W. Yancy, MD Presenters: Gurushner Panjrath, MD; Biykem Bozkurt, MD |
||||||
Session III: Heart Failure And Hypertension | ||||||||
9:05 - 9:10 am |
Chair Introduction |
Chair: Clyde W. Yancy, MD |
||||||
|
||||||||
9:55 - 10:15 am |
Panel Discussion and Q&A |
Chair: Clyde W. Yancy, MD |
||||||
10:20 - 10:50 am |
Morning Break & Exhibits |
|||||||
|
||||||||
|
||||||||
12:20 - 12:40 pm |
Panel Discussion and Q&A |
Chair: Clyde W. Yancy, MD |
||||||
12:40 pm |
Closing Remarks |
Chair: Clyde W. Yancy, MD |
||||||
12:50 - 2:05 pm |
CME Lunch Symposium |
Chair: Christie M. Ballantyne, MD |
||||||
Session IV: Diabetes Management | ||||||||
2:15 - 2:20 pm |
Chair Introduction |
Chair: Jay S. Skyler, MD |
||||||
2:20 - 2:50 pm |
Updates on CVOTs: Completed and Ongoing |
|||||||
2:50 - 3:20 pm |
SGLT2 Inhibitors: MOAs, Benefits, Outcomes, and Class Effect |
|||||||
3:20 - 3:50 pm |
GLP1 Agonists: MOAs, Benefits, Outcomes, and Differences Between Trials |
|||||||
3:55 - 4:25 pm |
Afternoon Break & Exhibits |
|||||||
4:30 - 5:00 pm |
Combination Therapy to Meet Glycemic Goals |
|||||||
5:00 - 5:25 pm |
Challenging Patient Cases: Are the Guidelines Still Relevant in 2018? |
Chair: Jay S. Skyler, MD |
||||||
5:25 - 5:45 pm |
Panel Discussion and Q&A |
Chair: Jay S. Skyler, MD |
||||||
5:45 - 5:50 pm |
Meeting Closing Remarks |
Chair: Jay S. Skyler, MD |